[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Infusion Pump Market - Industry Trends, Opportunities and Forecasts to 2023

January 2017 | 88 pages | ID: G7715546430EN
Knowledge Sourcing Intelligence LLP

US$ 3,800.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Infusion Pump Market is expected to witness a CAGR of 5.54% over the forecast period to grow to US$9.763 billion by 2023, growing from US$7.457 billion in 2018. The infusion pump is a medical device that is used to deliver fluids into a patient’s body to infuse nutrients or medications like insulin, other hormones, antibiotics, and pain relievers. Infusion pumps may be stationary or ambulatory that are designed to be to portable or wearable. Different types of infusion pumps like enteral pump, patient-controlled analgesia (PCA) pump and insulin pump are used for specialized purposes. Depending on the mechanism used they can be classified into syringe pump, elastomeric pump, peristaltic pump, multi-channel pump and smart pump. Geographically North America is the largest market for infusion pumps, followed by Europe, Asia-Pacific, and Latin America. Rising prevalence of chronic diseases, increasing healthcare expenditure and improving healthcare infrastructure are major growth drivers for the market.

Research Methodology

This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.

Industry Overview

In this section, the entire infusion pump market is explained along with various drivers, restraints and opportunities to its device market. A product pipeline has been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis.

Segmentation

The infusion pump market has been segmented based on type, mechanism, and geography as below:

By Type
Insulin Pump
PCA Pump
Enteral Pump
By Mechanism
Syringe Pump
Elastomeric pump
Peristaltic pump
Multi-channel pump
Smart Pump
By Application
Chemotherapy
Gastroenterology
Diabetes
Pain management
Haematology
Others
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
Middle East and Africa
Asia Pacific
Market Players

This Section deals with major players in the infusion pump market, their market shares, products, growth strategies, financials, and recent investments among others. Key industry players in the infusion pump market are Baxter, B. Braun Melsungen, Medtronic and Roche among others.
1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. INFUSION PUMP MARKET INDUSTRY OVERVIEW

4.1. Market Overview
4.2. Drivers, Restraints, and Opportunities
4.3. Industry Value Chain Analysis
4.4. Product Pipeline
4.5. Innovations
4.6. Industry Regulations
4.7. Scenario Analysis

5. INFUSION PUMP MARKET FORECAST BY TYPE (US$ BILLION)

5.1. Insulin Pump
5.2. PCA Pump
5.3. Enteral Pump

6. INFUSION PUMP MARKET FORECAST BY MECHANISM (US$ BILLION)

6.1. Syringe Pump
6.2. Elastomeric pump
6.3. Peristaltic pump
6.4. Multi-channel pump
6.5. Smart Pump

7. INFUSION PUMP MARKET FORECAST BY APPLICATION (US$ BILLION)

7.1. Chemotherapy
7.2. Gastroenterology
7.3. Diabetes
7.4. Pain management
7.5. Haematology
7.6. Others

8. INFUSION PUMP MARKET FORECAST BY GEOGRAPHY (US$ BILLION)

8.1. Americas
  8.1.1. North America
  8.1.2. South America
8.2. Europe Middle East and Africa
  8.2.1. Europe
  8.2.2. Middle East and Africa
8.3. Asia Pacific

9. COMPETITIVE INTELLIGENCE

9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players

10. COMPANY PROFILES

10.1. Baxter International, Inc.
10.2. B. Braun Melsungen
10.3. Medtronic, Inc.
10.4. Roche Holdings Ltd.
10.5. Johnson & Johnson
10.6. Pfizer Inc.
10.7. Novartis
10.8. Omnipod (Insulet Corp.)


More Publications